NWBO Now Seeks To Identify Hedge Funds Engaged in Spoofing
Northwest Biotherapeutics, Inc. (NWBO) challenges a protective order in a legal case involving allegations of illegal spoofing.
Citadel’s motion to dismiss has now been denied in NWBO case
The legal battle involving Citadel and NWBO continues as the court denies a motion to dismiss allegations of market manipulation.
Citadel, Virtu, Susquehanna Fight Biotech Company Lawsuit
Citadel and 7 other market makers have jointly filed motion to dismiss the lawsuit issued by cancer research company Northwest Therapeutics.
